Ocata Therapeutics Inc fka OCAT

[rocky301]

bsm,


selling there Blastomere Technology?

Not 100% sure what your question is. The Blastomere technology may be licensed out as it was with CHA in Korea but definitely not sold. I am guessing you mean other researchers or companies wanting to use cell lines derived from the Blastomere technology? If so, the Roslin deal, yet to be finalized, was set up to do just that. Let me know if that answered your question..thanks

"ACT and Roslin Cells will publish a commercialization license so that third parties will have a reasonable and predictable path to commercialization of products using the same hESC lines that they may use in animal model studies for preclinical data. Commercialization licenses will also provide access to the cell lines biologics master file in order to establish regulatory compliance. Proceeds from commercialization licenses, including milestone and royalty payments, will be shared between ACT and Roslin Cells."
http://www.advancedcell.com/news-and-media/press-releases/advanced-cell-technology-and-the-roslin-institute-announce-agreement-for-storage-and-distribution-of-/